Wells Fargo Reaffirms Their Hold Rating on Colgate-Palmolive (CL)

In a report released on January 30, Christopher Carey from Wells Fargo maintained a Hold rating on Colgate-Palmolive, with a price target of $94.00. The company’s shares closed last Friday at $90.29.

Claim 50% Off TipRanks Premium

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Carey covers the Consumer Defensive sector, focusing on stocks such as Church & Dwight, Clorox, and Conagra Brands. According to TipRanks, Carey has an average return of 0.6% and a 46.92% success rate on recommended stocks.

Currently, the analyst consensus on Colgate-Palmolive is a Moderate Buy with an average price target of $90.29, implying a 0.00% upside from current levels. In a report released yesterday, TipRanks – Google also reiterated a Hold rating on the stock with a $97.00 price target.

Based on Colgate-Palmolive’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $5.23 billion and a GAAP net loss of $37 million. In comparison, last year the company earned a revenue of $4.94 billion and had a net profit of $739 million

Based on the recent corporate insider activity of 56 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CL in relation to earlier this year. Most recently, in November 2025, Sally Massey, the CHRO of CL sold 1,237.00 shares for a total of $100,060.93.